These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2213396)

  • 1. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
    Giannini EH; Brewer EJ; Miller ML; Gibbas D; Passo MH; Hoyeraal HM; Bernstein B; Person DA; Fink CW; Sawyer LA
    J Pediatr; 1990 Oct; 117(4):645-52. PubMed ID: 2213396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
    Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis.
    Levinson JE; Baum J; Brewer E; Fink C; Hanson V; Schaller J
    J Pediatr; 1977 Nov; 91(5):799-804. PubMed ID: 333079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Maximov A; Vorontsov I; Fink CW; Newman AJ; Cassidy JT; Zemel LS
    N Engl J Med; 1992 Apr; 326(16):1043-9. PubMed ID: 1549149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension.
    Bello AE; Grahn AY; Ball J; Kent JD; Holt RJ
    Curr Med Res Opin; 2015 Mar; 31(3):407-20. PubMed ID: 25516006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
    Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
    J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kümmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz HI
    Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B
    Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study.
    Kvien TK; Høyeraal HM; Sandstad B
    Scand J Rheumatol; 1984; 13(4):342-50. PubMed ID: 6395321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibuprofen or aspirin in rheumatoid arthritis therapy.
    Blechman WJ; Schmid FR; April PA; Wilson CH; Brooks CD
    JAMA; 1975 Jul; 233(4):336-40. PubMed ID: 1095794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.
    Ruperto N; Lovell DJ; Quartier P; Paz E; Rubio-Pérez N; Silva CA; Abud-Mendoza C; Burgos-Vargas R; Gerloni V; Melo-Gomes JA; Saad-Magalhães C; Sztajnbok F; Goldenstein-Schainberg C; Scheinberg M; Penades IC; Fischbach M; Orozco J; Hashkes PJ; Hom C; Jung L; Lepore L; Oliveira S; Wallace CA; Sigal LH; Block AJ; Covucci A; Martini A; Giannini EH; ;
    Lancet; 2008 Aug; 372(9636):383-91. PubMed ID: 18632147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
    Yokota S; Imagawa T; Mori M; Miyamae T; Aihara Y; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
    Lancet; 2008 Mar; 371(9617):998-1006. PubMed ID: 18358927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, long-term evaluation of the safety and efficacy of ibuprofen syrup in children with juvenile chronic arthritis.
    Steans A; Manners PJ; Robinson IG
    Br J Clin Pract; 1990 May; 44(5):172-5. PubMed ID: 2202404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.
    Goodman S; Howard P; Haig A; Flavin S; Macdonald B
    J Rheumatol; 2003 Apr; 30(4):829-31. PubMed ID: 12672207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
    Lovell DJ; Giannini EH; Reiff AO; Kimura Y; Li S; Hashkes PJ; Wallace CA; Onel KB; Foell D; Wu R; Biedermann S; Hamilton JD; Radin AR
    Arthritis Rheum; 2013 Sep; 65(9):2486-96. PubMed ID: 23754188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effectiveness, pharmacokinetics, and safety of a paracetamol/ibuprofen fixed-dose combination in children undergoing adenotonsillectomy: A randomized, single-blind, parallel group trial.
    Playne R; Anderson BJ; Frampton C; Stanescu I; Atkinson HC
    Paediatr Anaesth; 2018 Dec; 28(12):1087-1095. PubMed ID: 30375109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.
    Neustadt DH
    J Rheumatol Suppl; 1997 Feb; 47():17-22. PubMed ID: 9035016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.